Contemporary Treatment of Locally Advanced Oral Cancer

David Kim, Ryan Li

Research output: Contribution to journalReview article

Abstract

At our institution, locally advanced oral cancer is most commonly treated with surgical resection, immediate reconstruction, and adjuvant radiotherapy with or without concurrent systemic therapy depending on final surgical pathologic analysis. There are patients with markedly advanced local or regional disease who unfortunately will have a low probability of cure. We counsel these patients on induction chemotherapy, emphasizing that this is unlikely to result in a smaller volume of surgical resection. In these patients, a good response to induction chemotherapy is more frequently followed by concurrent chemoradiotherapy. We have not been in the practice of commonly recommending definitive chemoradiotherapy for locally advanced oral cancer when upfront surgery is an option. However, as reviewed below, there is a significant rationale for definitive chemoradiotherapy in patients who are surgical candidates, with the hope of good oncologic outcomes, and potential functional organ preservation. The experts who report their experiences in the studies reviewed below provide a strong argument for considering this approach.

Original languageEnglish (US)
Article number32
JournalCurrent treatment options in oncology
Volume20
Issue number4
DOIs
StatePublished - Apr 1 2019

Fingerprint

Mouth Neoplasms
Chemoradiotherapy
Induction Chemotherapy
Organ Preservation
Adjuvant Radiotherapy
Therapeutics

Keywords

  • Immunotherapy
  • Neoadjuvant therapy
  • Oral cavity squamous cell carcinoma
  • Outcome
  • Primary chemoradiotherapy
  • Treatment

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Cite this

Contemporary Treatment of Locally Advanced Oral Cancer. / Kim, David; Li, Ryan.

In: Current treatment options in oncology, Vol. 20, No. 4, 32, 01.04.2019.

Research output: Contribution to journalReview article

@article{42869b7c6c814d73ac93703881bf0126,
title = "Contemporary Treatment of Locally Advanced Oral Cancer",
abstract = "At our institution, locally advanced oral cancer is most commonly treated with surgical resection, immediate reconstruction, and adjuvant radiotherapy with or without concurrent systemic therapy depending on final surgical pathologic analysis. There are patients with markedly advanced local or regional disease who unfortunately will have a low probability of cure. We counsel these patients on induction chemotherapy, emphasizing that this is unlikely to result in a smaller volume of surgical resection. In these patients, a good response to induction chemotherapy is more frequently followed by concurrent chemoradiotherapy. We have not been in the practice of commonly recommending definitive chemoradiotherapy for locally advanced oral cancer when upfront surgery is an option. However, as reviewed below, there is a significant rationale for definitive chemoradiotherapy in patients who are surgical candidates, with the hope of good oncologic outcomes, and potential functional organ preservation. The experts who report their experiences in the studies reviewed below provide a strong argument for considering this approach.",
keywords = "Immunotherapy, Neoadjuvant therapy, Oral cavity squamous cell carcinoma, Outcome, Primary chemoradiotherapy, Treatment",
author = "David Kim and Ryan Li",
year = "2019",
month = "4",
day = "1",
doi = "10.1007/s11864-019-0631-8",
language = "English (US)",
volume = "20",
journal = "Current Treatment Options in Oncology",
issn = "1527-2729",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Contemporary Treatment of Locally Advanced Oral Cancer

AU - Kim, David

AU - Li, Ryan

PY - 2019/4/1

Y1 - 2019/4/1

N2 - At our institution, locally advanced oral cancer is most commonly treated with surgical resection, immediate reconstruction, and adjuvant radiotherapy with or without concurrent systemic therapy depending on final surgical pathologic analysis. There are patients with markedly advanced local or regional disease who unfortunately will have a low probability of cure. We counsel these patients on induction chemotherapy, emphasizing that this is unlikely to result in a smaller volume of surgical resection. In these patients, a good response to induction chemotherapy is more frequently followed by concurrent chemoradiotherapy. We have not been in the practice of commonly recommending definitive chemoradiotherapy for locally advanced oral cancer when upfront surgery is an option. However, as reviewed below, there is a significant rationale for definitive chemoradiotherapy in patients who are surgical candidates, with the hope of good oncologic outcomes, and potential functional organ preservation. The experts who report their experiences in the studies reviewed below provide a strong argument for considering this approach.

AB - At our institution, locally advanced oral cancer is most commonly treated with surgical resection, immediate reconstruction, and adjuvant radiotherapy with or without concurrent systemic therapy depending on final surgical pathologic analysis. There are patients with markedly advanced local or regional disease who unfortunately will have a low probability of cure. We counsel these patients on induction chemotherapy, emphasizing that this is unlikely to result in a smaller volume of surgical resection. In these patients, a good response to induction chemotherapy is more frequently followed by concurrent chemoradiotherapy. We have not been in the practice of commonly recommending definitive chemoradiotherapy for locally advanced oral cancer when upfront surgery is an option. However, as reviewed below, there is a significant rationale for definitive chemoradiotherapy in patients who are surgical candidates, with the hope of good oncologic outcomes, and potential functional organ preservation. The experts who report their experiences in the studies reviewed below provide a strong argument for considering this approach.

KW - Immunotherapy

KW - Neoadjuvant therapy

KW - Oral cavity squamous cell carcinoma

KW - Outcome

KW - Primary chemoradiotherapy

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=85062958674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062958674&partnerID=8YFLogxK

U2 - 10.1007/s11864-019-0631-8

DO - 10.1007/s11864-019-0631-8

M3 - Review article

VL - 20

JO - Current Treatment Options in Oncology

JF - Current Treatment Options in Oncology

SN - 1527-2729

IS - 4

M1 - 32

ER -